Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 82.71

+2.2%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Scott H. Davis who wrote (2072)	7/7/1998 2:50:00 PM
From: tom jones	Read Replies (2) of 4676

To all: ISIS 2922 Questions and comments. ISIS 2922 was an open label test so the results are already known. From what I have read from Isis this drug worked when other drugs did not. What could the fda see to not approve this drug? This would be the first drug of its kind to be approved so the fda may be a little reluctant. The fda meeting is July 22. Does there have to be an outcome from this meeting or can they delay the decision? There is a very large wedge or triangle forming on the ISIP chart, so it looks like there will be a breakout up or down around July 22. We may be in luck here. The meeting is July 22 and the drug's number ends with 22 so the stock may go up to $22. CAUTION I do not know if this theory works. Comments please Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next